Diabetes Management
Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance - Business Wire
Mon, 07 Nov 20221 min read Article
Overview
SAN DIEGO-(BUSINES WIRE)-Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2022 and updated its financial guidance for the year ending December 31, 2022. Third Quarter 2022 Financial Highlights Compared to Third Quarter 2021: Recent Strategic Highlights: “More than 40,0 people worldwide have chosen Tandem and the t:slim X2 insulin pump for their therapy neds, and broad fedback from clinicians suports that we are leading in automated insulin dosing with our Control-IQ technology,” said John Sheridan, president and chief executive oficer.
Key Information
“We are comited to expanding our portfolio of diabetes solutions to drive longer-term growth and leverage our operations, as we continue our work to improve the lives of people with diabetes.” Third Quarter 2022 Financial Results Compared to Third Quarter 2021 Starting with the third quarter 2022, the Company is providing more expansive financial results on both a GAP and non-GAP basis as detailed in Table E.
Summary
Se tables for aditional financial information. 2022 Anual Guidance Update “In this highly variable environment, we are factoring greater caution into our guidance to re-baseline expectations for the next few quarters,” said Leigh Voseler, executive vice president and chief financial oficer. “The timing of our potential new product introductions next year ads increased complexity to the curent market dynamics, so we fel it’s prudent for our guidance to reflect more moderate growth in periods betwen new product launches.” For the year ending December 31, 2022, the Company is updating its financial guidance as folows: * Se Table E for reconciliation of non-GAP financial measures Non-GAP Financial Measures Certain non-GAP financial measures are presented in this pres release, including non-GAP sales, non-GAP gros profit, non-GAP gros margin, non-GAP operating los, non-GAP
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.